Nipro MedicaLyte Bicarbonate Powder recalled for high endotoxin levels in hemodialysis concentrate
Nipro Renal Solutions USA is recalling specific lots of MedicaLyte Bicarbonate Powder used in hemodialysis treatment. The powder contains higher-than-safe levels of endotoxins, which are bacterial contaminants that can cause serious reactions in patients undergoing dialysis. The affected lots were distributed nationwide and internationally.
From the FDA notice · Read the official notice ↗ · All Nipro recalls
What to do
- If you use or administer this product, check the lot number and expiration date against the recall notice.
- Contact your dialysis provider or Nipro immediately if you have this product in use.
- Do not use affected lots; follow your provider's instructions for safe replacement concentrate.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 4 products — see all of them.
Details
- Units affected
- 2,327 cases
- Illnesses reported
- None reported
- Manufactured in
- 509 Fishing Creek Rd, Lewisberry, PA, United States
- Classification
- Class II
- Recall number
- Z-3134-2026
In the FDA's words
- Description
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)) Hemodialysis concentrates contain high endotoxin levels DB+201-2.1: Lot -NDB5E004(exp.4/30/2027) DB+201-25: Lots - NDB5M011(Exp.12/05/2027, NDB4J003(exp.9/25/2026) Distribution: Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama. Affected quantity: 2,327 cases
- Hazard
- Hemodialysis concentrates contain high endotoxin levels
4 products in this recall
Nipro MedicaLyte and Citric Complete dialysis concentrates recalled for endotoxin
Nipro is recalling four hemodialysis concentrate products because they may contain high levels of endotoxin, a substance from bacteria. The recall covers about 13,000 cases and 100 drums across the US, Guatemala, and Panama, with US distribution in FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201Z-3133-2026 · 3,286 cases
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)) (this page)Z-3134-2026 · 2,327 cases
- Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25Z-3135-2026 · 7,770 cases
- Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)Z-3136-2026 · 100 drums/1072 cases